We have some comments, questions, or suggestions. Under 8.4 (Additional Documentation Requirements and Utilization Review), it includes RNs and LPNs as “non-licensed team members” who require sign off. They are licensed by the Board of Nursing. Under 3.3, we are interested in some additional definition of “medication prescription monitoring” please—is this referring to the PMP or does this simply mean monitoring for side effects? It appears that the requirements of these regulations go above the EBP, we’d request some reconsideration of that. Lastly, what is the rate for each “encounter” (H2041) please? Thank you